跳至主要内容
临床试验/CTRI/2019/05/019433
CTRI/2019/05/019433尚未招募未知

: Anti-Mullerian Hormone (AMH) Levels In Follicular Fluid As A Predictor Of Assisted Reproductive Technology (ART) Outcomes

il0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Women between 23-40 years of age undergoing ART includes In vitro insemination (IVI) and intracytoplasmic sperm injection (ICSI)

排除标准

  • Diminished ovarian reserve-defined as Serum AMH levels <1.1ng/dl or less than 4 follicles measuring 17mm each on day of trigger
  • Stage III-IV endometriosis
  • Intracytoplasmic sperm injection done using surgically retrieved spermatozoa
  • Cycles where no oocytes retrieved on the day of aspiration.

研究者

发起方
il

相似试验